Ondero Met 2.5/850mg Tablet

ONDERO MET 2.5/850MG TABLET

Ondero Met 2.5/850mg Tablet, manufactured by Lupin Ltd., is a combination medication designed for the effective management of Type 2 Diabetes Mellitus in adults. It works synergistically to help control high blood sugar levels.

Composition Each tablet contains:

• Linagliptin: 2.5 mg (a DPP-4 inhibitor)
• Metformin: 850 mg (a biguanide)

Uses Ondero Met 2.5/850mg Tablet is prescribed for the treatment of Type 2 Diabetes Mellitus, particularly when diet, exercise, and other conventional medicines do not provide adequate blood sugar control. It functions as an adjunct therapy alongside a proper diet and exercise regimen. This medication helps improve glycemic control by enhancing insulin sensitivity, decreasing hepatic glucose production, and increasing insulin release from the pancreas. Effective control of blood sugar levels helps to prevent serious diabetes-related complications such as kidney damage, eye damage, nerve problems, limb loss, heart disease, and stroke.

Dosage and Administration Take Ondero Met 2.5/850mg Tablet exactly as prescribed by your doctor. It should preferably be taken with meals to minimize gastrointestinal side effects. Swallow the tablet whole; do not crush, chew, or break it. For best results, it is advised to take it at the same time each day. Your doctor will determine the appropriate dosage based on your condition, blood sugar levels, and other medications you are taking.

Side Effects Common side effects may include:

• Nausea, vomiting, diarrhea, stomach pain
• Changes in taste (e.g., metallic taste)
• Headache, dizziness, fatigue
• Low blood sugar (hypoglycemia), especially when used with other antidiabetic medicines.

Serious, though rare, side effects can include lactic acidosis and vitamin B12 deficiency with long-term use. Consult your doctor if any side effects persist or worsen.

Precautions

• Medical Conditions: Inform your doctor if you have a history of kidney, liver, heart disease, or pancreatic issues. This medicine is not recommended for patients with severe kidney or liver impairment, severe uncontrollable diabetes, Type 1 diabetes, or diabetic ketoacidosis.
• Alcohol: Avoid alcohol consumption as it can increase the risk of low blood sugar and lactic acidosis.
• Pregnancy and Breastfeeding: Consult your doctor before taking this medicine if you are pregnant or breastfeeding.
• Interactions: Be sure to inform your doctor about all other medicines you are taking, as interactions can occur, potentially increasing the risk of hypoglycemia or other adverse effects.
• Monitoring: Regular monitoring of blood sugar levels and kidney function is recommended during treatment. Long-term use may require monitoring of vitamin B12 levels.
• Do not stop taking this medicine without consulting your doctor. It is not recommended for use in patients below 18 years of age.

Storage Store in a cool and dry place, away from sunlight, preferably below 30°C.

ONDERO MET 2.5/850MG TABLET is a combination medication containing Linagliptin and Metformin, used for the management of type 2 diabetes mellitus. It helps control blood sugar levels when diet and exercise alone are not sufficient.

Here are some frequently asked questions about ONDERO MET 2.5/850MG TABLET:

What is ONDERO MET 2.5/850MG TABLET used for?

ONDERO MET 2.5/850MG TABLET is used as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It is prescribed when the body does not produce enough insulin or when the body's insulin does not work as effectively as it should. This medicine is not recommended for type 1 diabetes or diabetic ketoacidosis.

How does ONDERO MET 2.5/850MG TABLET work?

This tablet combines two active ingredients: Linagliptin and Metformin, which work through complementary mechanisms to lower blood sugar levels. Linagliptin, a DPP-4 inhibitor, increases the levels of natural substances called incretins, which stimulate insulin release from the pancreas in a glucose-dependent manner and decrease glucagon production. Metformin, a biguanide, primarily works by reducing the production of glucose in the liver, decreasing the absorption of sugar from the intestines, and improving the body's sensitivity to insulin.

What is the usual dosage of ONDERO MET 2.5/850MG TABLET?

The dosage of ONDERO MET 2.5/850MG TABLET is individualized based on effectiveness and tolerability, but it should not exceed a maximum recommended total daily dose of 5 mg linagliptin and 2000 mg metformin. For patients not currently taking metformin, a typical starting dose might be 2.5 mg linagliptin/500 mg metformin twice daily. For those already on metformin, the dose of metformin is maintained, and linagliptin is added. The tablet should generally be taken twice daily with meals to help reduce stomach upset.

What are the possible side effects of ONDERO MET 2.5/850MG TABLET?

Common side effects can include nausea, stomach upset, diarrhea, altered taste (often metallic), headache, and sore throat. More serious, though rare, side effects include lactic acidosis (symptoms like unusual tiredness, dizziness, severe drowsiness, muscle pain, fast/difficult breathing) and pancreatitis (severe abdominal pain, nausea, vomiting). It can also cause severe and disabling joint pain or, in rare cases, bullous pemphigoid (large, hard skin blisters). Long-term use of metformin may also lead to vitamin B12 deficiency.

Is ONDERO MET 2.5/850MG TABLET safe during pregnancy or breastfeeding?

Linagliptin is generally not recommended during pregnancy due to limited safety information, though metformin is considered safe during pregnancy by some guidelines. For breastfeeding, it is not known if linagliptin passes into breast milk in clinically significant amounts, while metformin does pass into breast milk in small quantities and is generally considered safe for breastfeeding infants. It is crucial to discuss with your doctor if you are pregnant, planning to become pregnant, or breastfeeding, as they may recommend alternative treatments like insulin.

Can ONDERO MET 2.5/850MG TABLET be taken with other medications?

Yes, but caution is advised. Other diabetes medications, such as insulin or sulfonylureas, when taken with ONDERO MET, may increase the risk of hypoglycemia (low blood sugar). Certain drugs can also increase the risk of metformin-associated lactic acidosis, including those that impair kidney function, cause significant hemodynamic changes, or interfere with acid-base balance. Always inform your doctor about all current medicines, including over-the-counter drugs, vitamins, and herbal products, to avoid potential interactions.

What precautions should be taken while using ONDERO MET 2.5/850MG TABLET?

It is very important to have your progress checked regularly by your doctor through blood and urine tests, especially during the initial weeks of treatment. Avoid excessive alcohol intake, as it can increase the risk of lactic acidosis and severe low blood sugar. Inform your doctor if you have kidney disease, liver disease, a history of pancreatitis, or if you are scheduled for surgery or any X-ray/CT scan involving iodinated contrast agents, as the medication may need to be temporarily stopped. Stay well-hydrated to prevent dehydration, which can also increase the risk of lactic acidosis.

What happens if a dose of ONDERO MET 2.5/850MG TABLET is missed?

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to compensate for a missed one. Consistent medication adherence is important for managing diabetes.

How should ONDERO MET 2.5/850MG TABLET be stored?

Store the medicine in a closed container at room temperature, typically between 68°F and 77°F (20°C and 25°C), away from heat, moisture, and direct light. Keep the tablets dry and out of the reach of children. Do not store in moist or damp areas like bathrooms, and do not use outdated medicine.